Tweet
Euro Surveill. Surveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
Eurosurveillance, Volume 16, Issue 38, 22 September 2011
Surveillance and outbreak reports
Surveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010
M D Flores-Chavez<SUP>1</SUP>, F J Merino<SUP>2</SUP>, S Garc?a-Bujalance<SUP>3</SUP>, P Martin-Rabad?n<SUP>4</SUP>, P Merino<SUP>5</SUP>, I Garc?a-Bermejo<SUP>6</SUP>, A Delgado<SUP>7</SUP>, J Cuadros (
)<SUP>8</SUP>, Working Group on Chagas Disease of Autonomous Community of Madrid<SUP>9</SUP>
Citation style for this article: Flores-Chavez MD, Merino FJ, Garc?a-Bujalance S, Martin-Rabad?n P, Merino P, Garc?a-Bermejo I, Delgado A, Cuadros J, Working Group on Chagas Disease of Autonomous Community of Madrid. Surveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010. Euro Surveill. 2011;16(38):pii=19974. Available online: http://www.eurosurveillance.org/View...rticleId=19974
Date of submission: 28 February 2011 <HR>One of the most important modes of transmission of Trypanosoma cruzi infection in areas where it is not endemic is vertical transmission: from mother to child. The objective of this report is to assess the efficacy of different programmes of serological screening to monitor infection with T. cruzi in pregnant Latin American women living in Madrid (Spain). To achieve this, a retrospective study was undertaken from January 2008 to December 2010 in seven hospitals in the Autonomous Community of Madrid. Serological screening programmes were classified in two main strategies: a selective one (pregnant women from Bolivia) and a universal one (pregnant women from Latin America). A total of 3,839 pregnant women were tested and the overall prevalence was 3.96%. The rate of congenital transmission was 2.6%. The current monitoring programmes have variable coverage ranging between 26% (selective screening) and 100% (universal screening). Monitoring of pregnant women from Latin America only reaches full coverage if universal screening of pregnant women is carried out at any moment of pregnancy, including at delivery. A common national regulation is necessary in order to ensure homogenous implementation of screening.
- -------
Eurosurveillance, Volume 16, Issue 38, 22 September 2011
Surveillance and outbreak reports
Surveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010
M D Flores-Chavez<SUP>1</SUP>, F J Merino<SUP>2</SUP>, S Garc?a-Bujalance<SUP>3</SUP>, P Martin-Rabad?n<SUP>4</SUP>, P Merino<SUP>5</SUP>, I Garc?a-Bermejo<SUP>6</SUP>, A Delgado<SUP>7</SUP>, J Cuadros (
- Department of Parasitology, National Microbiology Centre, Instituto de Salud Carlos III (Carlos III Health Institute), Madrid, Spain
- Department of Microbiology and Parasitology, Hospital Universitario Severo Ochoa, Legan?s, Madrid, Spain
- Department of Microbiology and Parasitology, Hospital La Paz, Madrid, Spain
- Department of Microbiology, Hospital Gregorio Mara??n, Madrid, Spain
- Department of Microbiology, Tropical Medicine Unit, Hospital Cl?nico de San Carlos, Madrid, Spain
- Department of Microbiology, Hospital Universitario de Getafe, Madrid, Spain
- Department of Microbiology, Hospital Universitario Fundaci?n Alcorc?n, Madrid, Spain
- Department of Microbiology and Parasitology, Hospital Pr?ncipe de Asturias, Madrid, Spain
- The participants of this group are listed at the end of the article
Citation style for this article: Flores-Chavez MD, Merino FJ, Garc?a-Bujalance S, Martin-Rabad?n P, Merino P, Garc?a-Bermejo I, Delgado A, Cuadros J, Working Group on Chagas Disease of Autonomous Community of Madrid. Surveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010. Euro Surveill. 2011;16(38):pii=19974. Available online: http://www.eurosurveillance.org/View...rticleId=19974
Date of submission: 28 February 2011 <HR>One of the most important modes of transmission of Trypanosoma cruzi infection in areas where it is not endemic is vertical transmission: from mother to child. The objective of this report is to assess the efficacy of different programmes of serological screening to monitor infection with T. cruzi in pregnant Latin American women living in Madrid (Spain). To achieve this, a retrospective study was undertaken from January 2008 to December 2010 in seven hospitals in the Autonomous Community of Madrid. Serological screening programmes were classified in two main strategies: a selective one (pregnant women from Bolivia) and a universal one (pregnant women from Latin America). A total of 3,839 pregnant women were tested and the overall prevalence was 3.96%. The rate of congenital transmission was 2.6%. The current monitoring programmes have variable coverage ranging between 26% (selective screening) and 100% (universal screening). Monitoring of pregnant women from Latin America only reaches full coverage if universal screening of pregnant women is carried out at any moment of pregnancy, including at delivery. A common national regulation is necessary in order to ensure homogenous implementation of screening.